AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
AAPL   318.35 (+0.03%)
FB   227.22 (+0.78%)
GOOGL   1,428.35 (+0.71%)
AMZN   2,422.41 (+0.89%)
NVDA   344.84 (+1.58%)
CGC   17.86 (-17.77%)
MU   46.72 (+0.54%)
GE   6.65 (-2.06%)
TSLA   811.48 (+0.70%)
AMD   52.51 (+1.49%)
ACB   14.27 (-6.98%)
GILD   75.25 (-0.09%)
DIS   116.37 (-0.33%)
BA   146.48 (-2.23%)
Log in

NASDAQ:STMLStemline Therapeutics News Headlines

$11.86
0.00 (0.00 %)
(As of 05/29/2020 09:50 AM ET)
Add
Compare
Today's Range
$11.77
Now: $11.86
$11.88
50-Day Range
$4.73
MA: $8.28
$12.22
52-Week Range
$3.21
Now: $11.86
$18.22
Volume23,729 shs
Average Volume3.22 million shs
Market Capitalization$622.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.34

Headlines

Stemline Therapeutics (NASDAQ STML) News Headlines

Source:
DateHeadline
Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, Inc. and Willis Towers Watson Public Limited Company and Wright Medical Group N.V.Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, Inc. and Willis Towers Watson Public Limited Company and Wright Medical Group N.V.
finance.yahoo.com - May 28 at 11:53 AM
Stemline Therapeutics Inc (NASDAQ:STML) Given Consensus Recommendation of "Hold" by BrokeragesStemline Therapeutics Inc (NASDAQ:STML) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 23 at 2:42 AM
SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations
finance.yahoo.com - May 21 at 6:25 PM
STEMLINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of STML and Encourages Investors to Contact the FirmSTEMLINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of STML and Encourages Investors to Contact the Firm
finance.yahoo.com - May 19 at 3:23 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Stemline Pharmaceuticals, Inc. (NasdaqGS - STML)SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Stemline Pharmaceuticals, Inc. (NasdaqGS - STML)
finance.yahoo.com - May 18 at 6:57 PM
Stemline Therapeutics Inc (NASDAQ:STML) Expected to Announce Quarterly Sales of $11.89 MillionStemline Therapeutics Inc (NASDAQ:STML) Expected to Announce Quarterly Sales of $11.89 Million
www.americanbankingnews.com - May 16 at 4:58 AM
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: QUINTANA ENERGY SERVICES, INC. (NYSE - QES), STEMLINE THERAPEUTICS, INC. (NASDAQ - STML) AND WILLIS TOWERS WATSON, PLC (NASDAQ - WLTW)NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: QUINTANA ENERGY SERVICES, INC. (NYSE - QES), STEMLINE THERAPEUTICS, INC. (NASDAQ - STML) AND WILLIS TOWERS WATSON, PLC (NASDAQ - WLTW)
finance.yahoo.com - May 14 at 5:36 PM
Why Stemline Therapeutics (STML) Might Surprise This Earnings SeasonWhy Stemline Therapeutics (STML) Might Surprise This Earnings Season
finance.yahoo.com - May 14 at 12:35 PM
 Brokerages Anticipate Stemline Therapeutics Inc (NASDAQ:STML) Will Post Earnings of -$0.37 Per Share Brokerages Anticipate Stemline Therapeutics Inc (NASDAQ:STML) Will Post Earnings of -$0.37 Per Share
www.americanbankingnews.com - May 14 at 6:57 AM
Stemline Therapeutics (NASDAQ:STML) Announces  Earnings ResultsStemline Therapeutics (NASDAQ:STML) Announces Earnings Results
www.americanbankingnews.com - May 13 at 7:42 PM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLAINVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
finance.yahoo.com - May 13 at 2:24 PM
TG Therapeutics Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaTG Therapeutics Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - May 7 at 8:21 AM
Stemline Therapeutics (NASDAQ:STML) Getting Favorable Media Coverage, Report ShowsStemline Therapeutics (NASDAQ:STML) Getting Favorable Media Coverage, Report Shows
www.americanbankingnews.com - May 6 at 4:11 AM
Shareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLAShareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
finance.yahoo.com - May 6 at 1:37 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.
finance.yahoo.com - May 5 at 8:36 PM
Stemline Therapeutics (NASDAQ:STML) Rating Lowered to Neutral at Alliance Global PartnersStemline Therapeutics (NASDAQ:STML) Rating Lowered to Neutral at Alliance Global Partners
www.americanbankingnews.com - May 5 at 8:17 PM
Stemline Therapeutics (NASDAQ:STML) Downgraded by HC WainwrightStemline Therapeutics (NASDAQ:STML) Downgraded by HC Wainwright
www.americanbankingnews.com - May 5 at 7:45 PM
LADENBURG THALM/SH SH Lowers Stemline Therapeutics (NASDAQ:STML) to NeutralLADENBURG THALM/SH SH Lowers Stemline Therapeutics (NASDAQ:STML) to Neutral
www.americanbankingnews.com - May 5 at 7:45 PM
Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law FirmMoore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law Firm
finance.yahoo.com - May 5 at 3:36 PM
Shareholder Alert: Ademi & OReilly, LLP Investigates whether Stemline Therapeutics Inc. has obtained a Fair Price in its sale to Menarini GroupShareholder Alert: Ademi & O'Reilly, LLP Investigates whether Stemline Therapeutics Inc. has obtained a Fair Price in its sale to Menarini Group
finance.yahoo.com - May 5 at 10:35 AM
MVIS, STML, PBI and RRD among midday moversMVIS, STML, PBI and RRD among midday movers
seekingalpha.com - May 4 at 5:41 PM
Heres Why Stemline Therapeutics Doubled OvernightHere's Why Stemline Therapeutics Doubled Overnight
www.fool.com - May 4 at 5:41 PM
Stemline Stock Doubles After Up to $677M Purchase Accord With Menarini of ItalyStemline Stock Doubles After Up to $677M Purchase Accord With Menarini of Italy
www.thestreet.com - May 4 at 5:41 PM
Stemline rockets 151% premarket on Menarini bidStemline rockets 151% premarket on Menarini bid
seekingalpha.com - May 4 at 5:41 PM
Italys Menarini to buy Stemline Therapeutics in deal valued at up to $677 mlnItaly's Menarini to buy Stemline Therapeutics in deal valued at up to $677 mln
www.nasdaq.com - May 4 at 5:41 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Stemline Therapeutics, Inc. to Menarini Group is Fair to ShareholdersSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Stemline Therapeutics, Inc. to Menarini Group is Fair to Shareholders
finance.yahoo.com - May 4 at 5:41 PM
Shareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - TORC, STML, KLXEShareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - TORC, STML, KLXE
finance.yahoo.com - May 4 at 5:41 PM
Stemline Therapeutics (NASDAQ:STML) Lowered to "Neutral" at WedbushStemline Therapeutics (NASDAQ:STML) Lowered to "Neutral" at Wedbush
www.americanbankingnews.com - May 4 at 5:35 PM
Stemline Therapeutics (NASDAQ:STML) Earns Neutral Rating from Cantor FitzgeraldStemline Therapeutics (NASDAQ:STML) Earns Neutral Rating from Cantor Fitzgerald
www.americanbankingnews.com - May 4 at 3:12 PM
Stemline Therapeutics Sees Unusually Large Options Volume (NASDAQ:STML)Stemline Therapeutics Sees Unusually Large Options Volume (NASDAQ:STML)
www.americanbankingnews.com - May 4 at 11:36 AM
Stemline Therapeutics To Go Private In $667M TransactionStemline Therapeutics To Go Private In $667M Transaction
www.benzinga.com - May 4 at 10:41 AM
Menarini Group to buy Stemline Therapeutics in deal valued at up to $677 mlnMenarini Group to buy Stemline Therapeutics in deal valued at up to $677 mln
www.reuters.com - May 4 at 7:38 AM
Italys Menarini Group to acquire Stemline Therapeutics in deal valued at up to $677 millionItaly's Menarini Group to acquire Stemline Therapeutics in deal valued at up to $677 million
www.marketwatch.com - May 4 at 7:38 AM
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 MillionMenarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
finance.yahoo.com - May 4 at 7:38 AM
Italy's Menarini Group to acquire Stemline Therapeutics in deal valued at up to $677 millionItaly's Menarini Group to acquire Stemline Therapeutics in deal valued at up to $677 million
finance.yahoo.com - May 4 at 7:38 AM
Will Stemline Therapeutics (STML) Report Negative Q1 Earnings? What You Should KnowWill Stemline Therapeutics (STML) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 1 at 4:50 PM
What You Must Know About Stemline Therapeutics, Inc.'s (NASDAQ:STML) Beta ValueWhat You Must Know About Stemline Therapeutics, Inc.'s (NASDAQ:STML) Beta Value
finance.yahoo.com - May 1 at 4:50 PM
Stemline Therapeutics IncStemline Therapeutics Inc
www.bloomberg.com - April 22 at 11:24 AM
Wall Street Recommends Buying These 2 Falling KnivesWall Street Recommends Buying These 2 Falling Knives
finance.yahoo.com - April 13 at 3:55 PM
Stemline Therapeutics, Inc. Just Reported, And Analysts Assigned A US$19.75 Price TargetStemline Therapeutics, Inc. Just Reported, And Analysts Assigned A US$19.75 Price Target
finance.yahoo.com - March 17 at 2:31 PM
Edited Transcript of STML earnings conference call or presentation 16-Mar-20 12:00pm GMTEdited Transcript of STML earnings conference call or presentation 16-Mar-20 12:00pm GMT
finance.yahoo.com - March 17 at 8:52 AM
Stemline Therapeutics Inc (STML) Q4 2019 Earnings Call TranscriptStemline Therapeutics Inc (STML) Q4 2019 Earnings Call Transcript
www.nasdaq.com - March 16 at 11:29 PM
Stemline Therapeutics, Inc. (STML) CEO Ivan Bergstein on Q4 2019 Results - Earnings Call TranscriptStemline Therapeutics, Inc. (STML) CEO Ivan Bergstein on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 16 at 12:35 PM
Stemline Therapeutics Reports Fourth Quarter 2019 Financial ResultsStemline Therapeutics Reports Fourth Quarter 2019 Financial Results
finance.yahoo.com - March 13 at 8:54 PM
Stemline Therapeutics (STML) Reports Q4 Loss, Tops Revenue EstimatesStemline Therapeutics (STML) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 13 at 8:54 PM
Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020
finance.yahoo.com - March 11 at 5:31 PM
Stemline Therapeutics to Present at the Cowen 40th Annual Health Care ConferenceStemline Therapeutics to Present at the Cowen 40th Annual Health Care Conference
finance.yahoo.com - February 26 at 9:19 AM
Stemline Therapeutics Announces Three SL-401 Clinical Presentations, Including an Oral Presentation, at the Upcoming EHA CongreStemline Therapeutics Announces Three SL-401 Clinical Presentations, Including an Oral Presentation, at the Upcoming EHA Congre
www.bloomberg.com - February 16 at 6:34 PM
Stemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRIS® (tagraxofusp) and Highlights Commercial andStemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRIS® (tagraxofusp) and Highlights Commercial and
www.bloomberg.com - February 15 at 12:22 AM
STEMLINE THERAPEUTICS, INC. INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Stemline Therapeutics, Inc.STEMLINE THERAPEUTICS, INC. INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Stemline Therapeutics, Inc.
finance.yahoo.com - February 4 at 6:51 PM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.